| 1. |
Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab, 2013, 98(3): 1122-1129.
|
| 2. |
Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, et al. Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. World J Surg, 2016, 40(10): 2359-2377.
|
| 3. |
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer1, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11): 1167-1214.
|
| 4. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
|
| 5. |
劉寧, 韓彬, 韋偉. 納米碳負顯影甲狀旁腺在甲狀腺癌手術中的應用價值. 廣東醫學, 2014, 35(12): 1918-1920.
|
| 6. |
朱精強, 汪洵理, 魏濤, 等. 納米碳甲狀旁腺負顯影辨認保護技術在甲狀腺癌手術中的應用. 中國普外基礎與臨床雜志, 2013, 20(9): 992-994.
|
| 7. |
中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺手術中甲狀旁腺保護專家共識. 中國實用外科雜志, 2015, 35(7): 731-736.
|
| 8. |
Eastell R, Brandi ML, Costa AG, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab, 2014, 99(10): 3570-3579.
|
| 9. |
Bilezikian JP, Khan AA, Potts JT Jr; Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism.Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab, 2009, 94(2): 335-339.
|
| 10. |
Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab, 2002, 87(12): 5353-5361.
|
| 11. |
Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease—a review. Eur Heart J, 2004, 25(20): 1776-1787.
|
| 12. |
Cansu GB, Y?lmaz N, ?zdem S, et al. Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. Clin Endocrinol (Oxf), 2016, 84(1): 39-47.
|
| 13. |
Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of hyperparathyroidism. J Clin Pathol, 2015, 68(10): 771-787.
|
| 14. |
Zanocco KA, Wu JX, Yeh MW. Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery, 2017, 161(1): 16-24.
|
| 15. |
Maruani G, Hertig A, Paillard M, et al. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab, 2003, 88(10): 4641-4648.
|
| 16. |
Bergenfelz A, Lindblom P, Linderg?rd B, et al. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism. World J Surg, 2003, 27(4): 481-485.
|
| 17. |
K?sem M, Algün E, Kotan C, et al. Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chir Belg, 2004, 104(5): 568-571.
|
| 18. |
Lee JK, Obrzut SL, Yi ES, et al. Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism. Endocr Pract, 2007, 13(4): 380-383.
|
| 19. |
Riss P, Kammer M, Selberherr A, et al. Morbidity Associated with Concomitant Thyroid Surgery in Patients with Primary Hyperparathyroidism. Ann Surg Oncol, 2015, 22(8): 2707-2713.
|
| 20. |
Nied?wiecki S, Kuzdak K, Kaczka K, et al. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer—preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology. Wiad Lek, 2007, 60(5-6): 228-230.
|
| 21. |
蘇磊, 王雪晨, 姚永忠, 等. 原發性甲狀旁腺功能亢進癥合并甲狀腺疾病的診治體會. 中國普外基礎與臨床雜志, 2010, 17(12): 1290-1293.
|
| 22. |
Bilezikian JP, Silverberg SJ, Rubin M, Jr JTP. Asymptomatic primary hyperparathyroidism: Present management and future options. 2006;3:132-40.
|
| 23. |
Morris GS, Grubbs EG, Hearon CM, et al. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg, 2010, 251(5): 832-837.
|
| 24. |
中華醫學會骨質疏松和骨礦鹽疾病分會, 中華醫學會內分泌分會代謝性骨病學組. 原發性甲狀旁腺功能亢進癥診療指南. 中華骨質疏松和骨礦鹽疾病雜志, 2014, 7(3): 187-198.
|
| 25. |
朱信心, 魏濤, 龔日祥, 等. 136 例原發性甲狀旁腺功能亢進的診治體會. 中國普外基礎與臨床雜志, 2014, 21(4): 452-457.
|
| 26. |
胡章, 張純海. 原發性甲狀旁腺功能亢進癥的臨床資料分析. 吉林大學, 2016.
|
| 27. |
吳全, 崔愛民, 柏楠, 等. 73 例原發性甲狀旁腺功能亢進癥的診治分析. 中國普外基礎與臨床雜志, 2013, 20(7): 776-781.
|